USE AND MISUSE OF BENZODIAZEPINES IN BRAZIL: A REVIEW

REFERENCES

• World Health Organization. Programme on Substance Abuse –Rational Use of Benzodiazepines (N° 96.11). WHO: Geneva, 1996
   Google Scholar
• Greenblatt D. J., Shader R. I., Koch-Weser J. Psychotropic drug use in the Boston area. Arch. Gen. Ps ychiatry 1975; 32: 518–521
   PubMed Web of Science ®Google Scholar
• Almeida L. M., Coutinho E. S.F., Pepe V. L.E. Consumo de Psicofármacos em uma Região Administrativa do Rio de janeiro. A Ilha do Governador. Cad. Saude Públ. 1994; 10(1)5–16
   PubMedGoogle Scholar
• Hollister L. E. Principles of therapeutic applications of benzodiazepines. The Benzodiazepines: Current Standards for Medical Practice, D. E. Smith, D. R. Wesson. MTP Press, LancasterEngland 1985; 87–96
   Google Scholar
• Warneke L. B. Benzodiazepines: abuse and new use. Can. J. Psychiatry 1991; 36: 194–202
   PubMed Web of Science ®Google Scholar
• Laux G., Konig W. Benzodiazepine: Laugzeteinnaahme oder Abusus. Dtsch. Med. Wochenschr 1985; 34: 285–290
   Google Scholar
• Marks J. The benzodiazepines: Use, Overuse, Misuse, Abuse. MTP Press, London 1985
   Google Scholar
• Dunbar G. C., Morgan D. D., Perera K. M. Concurrent use of alcohol, cigarettes and caffeine in British benzodiazepine users as measured by a general population survey. Br. J. Psychiatry 1989; 155: 836–841
   PubMed Web of Science ®Google Scholar
• Herings R. M.C. Geneesmiddelen aspecten van chronisch gebruik van slaap en Kalemringsmiddelen. Chronisch Gebruik van Slaap en Kalmeringsmiddelen.(RI VM report 319002001), J. W. van der Laan, et al. RIVM, Bilthoven 1991
   Google Scholar
• Humphreys A. S., Hallström C. Benz odiazepine discontinuation phenomena. Ballière's Clinical Psychiatry. International Practice and research. Hypnotics and Anxiolytics, D. J. Nutt, W. B. Mendelson. Ballière Tindall, London 1995; 485–503
   Google Scholar
• Wortmann A. C., et al. Consumo de benzodiazepínicos em Porto Alegre. Ver. Ass. Med. Brasil 1994; 40(4)265–270
   PubMedGoogle Scholar
• Gentil-Filho V. Psicofarmacologia – 40 anos: Uma síntese crítica. Revista de Psiquiatria Clínica 1992; 15–19, (especial)17–23
   Google Scholar
• Coutinho E. S.F., Klein C. H., Morgado A. F., Iguchi T., Souza E. R. Confiabilidade do diagnóstico psiquiátrico em hospitais do Rio de Janeiro. J. Brasileiro Psiquiatria 1988; 37: 197–200
   Google Scholar
• Ame rican Psychiatric Association. Task Force Report: Benzodiazepine Dependence, Toxicity, and Abuse. APA, Washington, DC 1990
   Google Scholar
• KrauplTaylor F. The damnation of banzodiazepines. Br. J. Psychiatry 1989; 154: 697–704
   PubMedGoogle Scholar
• Woods J. H., Katz J. L., Winger G. D. Restricting benzodiazepine prescribing. Lancet 1991; 337: 295
   PubMedGoogle Scholar
• Ruiz I., Oermanns J., Lanctôt K. L., Busto U. Comparative study on benzodiazepine use in Canada and Chile. J. Clin. Pharmacol. 1993; 33: 124–129
   PubMed Web of Science ®Google Scholar
• Danhier A., Brieva J., Villegas G., Yates T., Pérez H. Estudio de la Utilización de psicofármacos en la ciudad de Concepción. Ver Chil Neuropsiquiatría 1988; 26: 32–38
   Google Scholar
• Busto E. U., Ruiz I., Busto M., Gacitua A. Benzodiazepine use in Chile: impact of availability on use, abuse and dependence. J. Clin. Psychopharmacol. 1996; 16(5)363
   PubMedGoogle Scholar
• Organisation Mondiale de la Santé. La Situation Pharmaceutique dans le Monde. OMS, Genève 1990
   Google Scholar
• CEME/MS (Central de Medicamentos do Ministério da Saúde). Medicamentos Essenciais: Os Caminhos da Autonomia. Document o-Proposta, Brasília 1987, DF:CEME/MS.(Mim eo.)
   Google Scholar
• Tancredi F. B. Aspectos Epidemiológicos do Consumo de medicamentos psicotrópicos pela Populacçãade Adultos do Distrito de São Paulo, Tese de Mestrado. Faculdade de Saúde Pública, São Paulo 1979, Universidade de São Paulo
   Google Scholar
• Mari J. J., Almeida-Filho N., Coutinho E., Andreoli S. B., Miranda C. T., Streiner D. The epidemiology of psychotropic use in the City of São Paulo. Psychologic Medicine 1993; 23: 467–474
   PubMed Web of Science ®Google Scholar
• Balter M. B. Prevalence of medical use of prescription drugs. Presented at NIDA technical review. Eva luation of the impact of prescription drug diversion control systems on medical practice and patient care: possible implications for future research. Bethesda MD: NIDA, June. 1991
   Google Scholar
• Lima M. S., Hotopf M., Mari J. J., Béria J. U., De Bastos A. B., Mann A. Ps ychiatric disorder and the use of benzodiazepines: an example of the inverse care law from Brazil. Soc. Psychiatr. Epidemiol. 1999; 34(6)316–322
   PubMedGoogle Scholar
• Hart J. T. The inverse care law. Lancet 1971; 1: 405–412
   PubMed Web of Science ®Google Scholar
• Lima M. S. Morbidade Psiquiátrica Menor e Consumo de Psicofármacos em Pelotas, RS.[Master Thesis]. Pelotas (RS). Mestrado em Epidemiologia da Faculdade de Medicina da Universidade Federal de Pelotas 1995
   Google Scholar
• Horta B. L., de Lima M. S., Faleiros J. J., Weiderpass E., Horta R. L. Benzodiazepines: prescription study in a primary health care unit. Rev. Assoc. Med. Bras. 1994; 40(4)262–264
   PubMedGoogle Scholar
• Karniol et al. Uso e Abuso de Benzodiazepinas no Brasil. Revista ABP-APAL 1986; 8(1)30–35
   Google Scholar
• Brahams D. Benzodiazepine overprescribing succesful initiative in New York state. Lancet 1990; 335: 1372–1373
   Google Scholar
• Shader R. I., Greenblatt D. J., Balter M. B. Apropriate use and regulatory control of benzodiazepines. J. Clin. Pharmacol. 1991; 31: 781–784
   PubMedGoogle Scholar
• Appellbaum P. S. Controling prescription of benzodiazepines. Hosp. Commun Psychiatry 1992; 43(1)12–13
   PubMedGoogle Scholar
• New York State Department of Health. Benzodiazepines: Prescribing Declines Under Triplicate Program Epidemiology Note 4(12). Albany, 1989
   Google Scholar
• New York State Department of Health. Regulation Placing Benzodiazepines on Triplicate Prescription: The First Year, 1989 Albany, 1990
   Google Scholar
• New York State Department of Health. Benzodiazepines: Additional Effects of the Triplicate Program Epidemiology Note 5(1). Albany, 1990
   Google Scholar
• Carlini E. A., Masur J., Formigoni M. L.O.S. A influência de uma legislação mais restritiva na venda de medicamentos psicotrópicos. Revista APB-APAL 1988; 10(1)12–15
   Google Scholar
• Carlini E. A., Masur J. Venda de medicamentos sem receita médica nas farméciad da cidade de São Paulo. Revi sta da Associação Médica Brasileira 1986; 3: 75–78
   Google Scholar
• Pan American Health Organization. Special report – epidemiologic report on the use and abuse of psychoactive substances in 16 countries of Latin America and the Caribbean. PAHO Bull. 1990; 24(1)97–140
   Google Scholar